Back

Effect of primary prevention on major adverse cardiac event in breast cancer patients on cytotoxic chemotherapy

19 June 2026 (10:45 - 11:30)
Organised by: Logo
Congress Presentation Part of: Preventing cardiotoxicity Stratification, Prevention and Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mr Aniket Kawatkar

Kaiser Permanente - Pasadena Medical Offices, Pasadena (United States of America)

5 More presentations in this session

Presentation thumbnail
Effects of tailored exercise prescription on cardiorespiratory fitness in breast cancer survivors: findings from the munich cardio-oncology-exercise retrospective registry
Ms L. Kuehberger (Munich, DE)
Abstract Slides
Presentation thumbnail
Insufficient control of classical atherosclerotic risk factors in patients with non-metastatic breast cancer referred for anticancer therapy
Doctor S. Medrek (Brzozow, PL)
Abstract Slides
Presentation thumbnail
Exploring the relationship between oral health and cancer therapy related cardiac dysfunction in HER2-positive breast cancer patients
Doctor A. Basuoni (Muscat, OM)
Abstract Slides
Presentation thumbnail
Efficacy of beta-blockers in preventing anthracycline-induced cardiotoxicity: updated meta-analysis of randomized controlled trials
Doctor P. Silva De Marco (Sao Jose do Rio Preto, BR)
Abstract Slides
Presentation thumbnail
A digital tool developed by multidisciplinary physicians to improve prostate cancer management: cardiovascular prevention and drug-drug interaction
Doctor E. Mervoyer (Nantes, FR)
Abstract Slides

Access the full session

Session thumbnail
Preventing cardiotoxicity

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 10:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources